Massachusetts Court Reviews Cannabis Policy Initiative
The Massachusetts Supreme Judicial Court (SJC) recently heard arguments in a case challenging a ballot initiative that could significantly alter the state’s regulated cannabis industry, including implications for medical cannabis access. The case, Caroline Pineau, et al. v. Attorney General and Secretary of State, SJC-13927, concerns an initiative titled “An Act to Restore a Sensible Marijuana Policy.” If the SJC does not rule in favor of the challengers, this initiative is expected to appear on the November ballot, potentially repealing laws governing adult-use cannabis and impacting the medical sector.
The Initiative and Legal Arguments
The proposed initiative seeks to repeal Chapters 94G and 64N of the General Laws, which currently regulate the possession, use, distribution, cultivation, and taxation of non-medically prescribed marijuana. While the petition states it would “continu[e] the medical program,” plaintiffs and industry groups argue its broader effects would extend to medical cannabis access and patient care.
Plaintiffs in the suit, represented by Vicente LLP’s Adam Fine and Tim Swain, are registered Massachusetts voters and recipients of cannabis social equity grants. They contend that the petition violates constitutional standards by incorporating unrelated and, in some instances, contradictory policies. A key argument highlighted during oral arguments was that the initiative would eliminate the state’s social equity mandate, designed to foster participation in the regulated marijuana industry by communities disproportionately affected by prior prohibition. This includes the potential dissolution of policies supporting social equity applicants and the dedicated Social Equity Trust Fund. Additionally, the plaintiffs raised concerns that the initiative would increase penalties for simple marijuana possession.
The Massachusetts Cannabis Coalition (MCC), the state’s largest cannabis industry group, participated as an amicus curiae (friend of the court), represented by Christine Baily of C Bailey Law LLC, as reported by Marijuana Moment. The MCC’s brief argued that the Attorney General’s certification and summary of the petition were based on an outdated version of state law. Consequently, voters might consider a petition without full awareness of the substantial amendments it would introduce. The MCC also asserted that neither the petition nor its summary accurately conveyed the full impact of the proposed repeal on the medical program and patient access. The Massachusetts Cannabis Control Commission (CCC), the state’s regulatory body for both adult-use and medical programs, has historically interpreted these programs as interrelated, suggesting that a partial repeal could not surgically separate them without broader consequences. The MCC’s brief further warned that the repeal could affect individuals using adult-use cannabis for therapeutic purposes and eliminate the requirement for municipalities to enter host community agreements, a mechanism for addressing public health concerns.
Court’s Deliberation and Potential Outcomes
Challenges to an Attorney General’s certification and summary of a ballot petition are generally difficult to win. During Monday’s oral argument, the SJC justices appeared cognizant of the constitutional right of Massachusetts voters to enact legislation via the ballot box. A decision from the SJC is anticipated by June.
Even if the court ultimately rules against the plaintiffs and permits the petition to be placed on the November ballot, the litigation has served to highlight the potential ramifications for the industry and for medical cannabis access. The MCC’s Executive Director, Dominguez, said in a statement that the group is “standing up for both the cannabis industry and the will of the voters,” emphasizing the need for voters to be informed about the initiative’s potential to dismantle the legalized industry, recriminalize possession, and minimize patient access, as reported by Marijuana Moment. The legal challenge has aimed to expose omissions in the Attorney General’s summary and clarify the consequences of repealing parts of the state’s cannabis laws, intending to inform Massachusetts voters about what is at stake for the industry.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
